Malignant Neoplasm of Unknown Primary — Trials

Malignant Neoplasm of Unknown Primary — Trials · CancerIndex

Clinical trials

Registered studies

14,253 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 4,158
Recruiting: 2,260
Ph III recruiting: 268
Growth YoY: +13.9%
Industry share: 23%
Top sponsor: National Cancer Institute (NCI)
Termination share: 35.4%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1,895)

clinicaltrialsPublishedShowing 201–205 of 205 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00554125	Sirolimus-Based Immunosuppression Therapy in OLT for Patients With HCC Exceeding Milan Criteria	unknown	Phase 3	220	Fudan UniversityOTHER	1	Nov 6, 2007	clinicaltrials
NCT00460681	Study of Thymopentin in Patients After Curative Resection of Small Hepatocellular Carcinoma	unknown	Phase 3	220	Fudan UniversityOTHER	1	Oct 31, 2007	clinicaltrials